Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.

A total of 535 chemotherapy naive, hospitalised patients (263 male/272 female) scheduled to receive cisplatin (50-120 mg m-2)-containing regimens participated in a randomised, double-blind, parallel group study to evaluate the efficacy and safety of three intravenous dose schedules of ondansetron in...

Descripción completa

Detalles Bibliográficos
Autores principales: Seynaeve, C., Schuller, J., Buser, K., Porteder, H., Van Belle, S., Sevelda, P., Christmann, D., Schmidt, M., Kitchener, H., Paes, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977922/
https://www.ncbi.nlm.nih.gov/pubmed/1386245

Ejemplares similares

Ejemplares similares